niacinamide has been researched along with Brain Swelling in 20 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Brain edema was produced by 6-aminonicotinamide (6-AN) in the rat with accompanying metabolic disturbance due to the accumulation of an antimetabolite of nicotinamide in the CNS." | 7.66 | Brain edema and gliopathy induced by 6-aminonicotinamide intoxication in the central nervous system of rats. ( Sasaki, S, 1982) |
| "Brain edema was produced by 6-aminonicotinamide (6-AN) in the rat with accompanying metabolic disturbance due to the accumulation of an antimetabolite of nicotinamide in the CNS." | 3.66 | Brain edema and gliopathy induced by 6-aminonicotinamide intoxication in the central nervous system of rats. ( Sasaki, S, 1982) |
| "Ischemic stroke is one of the leading causes of human death and disability." | 1.72 | Acutely Inhibiting AQP4 With TGN-020 Improves Functional Outcome by Attenuating Edema and Peri-Infarct Astrogliosis After Cerebral Ischemia. ( Hao, X; Li, C; Lin, L; Ren, Y; Sun, C; Tian, J; Yang, Y; Yin, L; Zhang, X, 2022) |
| "High altitude cerebral edema (HACE) is a fulminant, deadly, and yet still unpredictable brain disease." | 1.43 | Preventing High Altitude Cerebral Edema in Rats with Repurposed Anti-Angiogenesis Pharmacotherapy. ( Irwin, DC; Loomis, Z; Maltzahn, J; Tarshis, S, 2016) |
| "Patients with renal cell and breast carcinoma metastases to the brain were identified from the prospective database at the Penn State Hershey Medical Center and Penn State Cancer Institute." | 1.35 | Brain magnetic resonance imaging changes after sorafenib and sunitinib chemotherapy in patients with advanced renal cell and breast carcinoma. ( Hill, KL; Lipson, AC; Sheehan, JM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (45.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, C | 1 |
| Lin, L | 1 |
| Yin, L | 1 |
| Hao, X | 1 |
| Tian, J | 1 |
| Zhang, X | 1 |
| Ren, Y | 1 |
| Li, C | 1 |
| Yang, Y | 1 |
| Tarshis, S | 1 |
| Maltzahn, J | 1 |
| Loomis, Z | 1 |
| Irwin, DC | 1 |
| Zhang, J | 1 |
| Xu, X | 1 |
| Zhou, D | 1 |
| Li, H | 1 |
| You, W | 1 |
| Wang, Z | 1 |
| Chen, G | 1 |
| Leitão, RA | 1 |
| Sereno, J | 1 |
| Castelhano, JM | 1 |
| Gonçalves, SI | 1 |
| Coelho-Santos, V | 1 |
| Fontes-Ribeiro, C | 1 |
| Castelo-Branco, M | 1 |
| Silva, AP | 1 |
| Hill, KL | 1 |
| Lipson, AC | 1 |
| Sheehan, JM | 1 |
| Igarashi, H | 1 |
| Huber, VJ | 1 |
| Tsujita, M | 1 |
| Nakada, T | 1 |
| Swan, AA | 1 |
| Chandrashekar, R | 1 |
| Beare, J | 1 |
| Hoane, MR | 1 |
| Leker, RR | 1 |
| Asano, T | 3 |
| Johshita, H | 2 |
| Koide, T | 3 |
| Takakura, K | 3 |
| Sasaki, S | 1 |
| Yoshimura, N | 1 |
| Okada, M | 1 |
| Ota, T | 1 |
| Nohara, H | 1 |
| Kamada, K | 2 |
| Houkin, K | 1 |
| Iwasaki, Y | 1 |
| Abe, H | 1 |
| Raedler, A | 1 |
| Sievers, J | 1 |
| Matsushita, H | 1 |
| Gotoh, O | 1 |
| Usui, M | 1 |
| Shigeno, T | 1 |
| Baethmann, A | 3 |
| Reulen, HJ | 2 |
| Brendel, W | 2 |
| Van Harreveld, A | 1 |
| Meyer-König, E | 1 |
1 review available for niacinamide and Brain Swelling
| Article | Year |
|---|---|
Nicaraven Chugai.
Topics: Animals; Antioxidants; Brain Edema; Brain Ischemia; Cerebral Hemorrhage; Clinical Trials, Phase I as | 2003 |
19 other studies available for niacinamide and Brain Swelling
| Article | Year |
|---|---|
Acutely Inhibiting AQP4 With TGN-020 Improves Functional Outcome by Attenuating Edema and Peri-Infarct Astrogliosis After Cerebral Ischemia.
Topics: Animals; Aquaporin 4; Brain Edema; Brain Ischemia; Gliosis; Infarction, Middle Cerebral Artery; Magn | 2022 |
Preventing High Altitude Cerebral Edema in Rats with Repurposed Anti-Angiogenesis Pharmacotherapy.
Topics: Acetazolamide; Altitude; Altitude Sickness; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; A | 2016 |
Possible Role of Raf-1 Kinase in the Development of Cerebral Vasospasm and Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats.
Topics: Animals; Basilar Artery; Blood-Brain Barrier; Brain Damage, Chronic; Brain Edema; Cyclooxygenase 2; | 2015 |
Aquaporin-4 as a New Target against Methamphetamine-Induced Brain Alterations: Focus on the Neurogliovascular Unit and Motivational Behavior.
Topics: Animals; Aquaporin 4; Blood-Brain Barrier; Brain; Brain Edema; Locomotion; Male; Methamphetamine; Mi | 2018 |
Brain magnetic resonance imaging changes after sorafenib and sunitinib chemotherapy in patients with advanced renal cell and breast carcinoma.
Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Brain; Brain Edema; Brain Neoplasms; Breast Neoplasm | 2009 |
Pretreatment with a novel aquaporin 4 inhibitor, TGN-020, significantly reduces ischemic cerebral edema.
Topics: Analysis of Variance; Animals; Aquaporin 4; Brain Edema; Brain Ischemia; Cerebrovascular Circulation | 2011 |
Preclinical efficacy testing in middle-aged rats: nicotinamide, a novel neuroprotectant, demonstrates diminished preclinical efficacy after controlled cortical impact.
Topics: Age Factors; Analysis of Variance; Animals; Astrocytes; Blood-Brain Barrier; Brain Edema; Brain Inju | 2011 |
Amelioration of ischaemic cerebral oedema by a free radical scavenger, AVS: 1,2-bis(nicotinamido)-propane. An experimental study using a regional ischaemia model in cats.
Topics: Animals; Brain Edema; Brain Ischemia; Cats; Cerebral Cortex; Disease Models, Animal; Energy Metaboli | 1984 |
Brain edema and gliopathy induced by 6-aminonicotinamide intoxication in the central nervous system of rats.
Topics: 6-Aminonicotinamide; Animals; Astrocytes; Blood-Brain Barrier; Brain Edema; Male; Neuroglia; Niacina | 1982 |
Pharmacologic intervention for ischemic brain edema after retrograde cerebral perfusion.
Topics: Animals; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Brain; Brain Edema; Brain Ischemia; Cardiopulmo | 1995 |
A high-field magnetic resonance imaging study of experimental vasogenic brain edema and its response to AVS: 1,2-bis (nicotinamido)-propane.
Topics: Animals; Antioxidants; Blood-Brain Barrier; Brain Edema; Brain Injuries; Cerebral Cortex; Corpus Cal | 1994 |
[Sequential observations of brain edema with proton magnetic resonance imaging and spectroscopy].
Topics: Aged; Animals; Brain Edema; Female; Free Radical Scavengers; Glutamine; Humans; Lactates; Magnetic R | 1996 |
Influences of experimental brain edema on the development of the visual system.
Topics: Age Factors; Animals; Animals, Newborn; Antimetabolites; Brain Edema; Brain Stem; Cell Differentiati | 1975 |
Enhancement of ATPase activity by a lipid peroxide of arachidonic acid in rat brain microvessels.
Topics: Adenosine Triphosphatases; Animals; Arachidonic Acids; Brain; Brain Edema; Ca(2+) Mg(2+)-ATPase; Dos | 1986 |
[The pathomechanism underlying ischemic brain edema: the role of Na+, K+-ATPase of the brain microvessels].
Topics: Animals; Brain Chemistry; Brain Edema; Brain Ischemia; Cats; Cerebrovascular Circulation; Disease Mo | 1985 |
[The effect of the Antimetabolite 6-aminonicotinamide (6-ANA) on the water- and electrolyte content in the brain of rats and its inhibition by niacin].
Topics: Animals; Biological Transport, Active; Brain; Brain Edema; Myocardium; Niacinamide; Nicotinic Acids; | 1968 |
Water and electrolyte distribution in gray matter rendered edematous with a metabolic inhibitor.
Topics: Animals; Antimetabolites; Brain Edema; Cerebellum; Cerebral Cortex; Craniotomy; Disease Models, Anim | 1973 |
[Ultrastructure of glial and axonal changes in the optic nerve of the rat induced by 6-aminonicotinamide (author's transl)].
Topics: Animals; Axons; Brain Edema; Endoplasmic Reticulum; Microscopy, Electron; Nerve Degeneration; Neurog | 1973 |
[Experimental brain edema caused by 6-aminonicotinamide--an antimetabolite of nicotinic acid].
Topics: Animals; Antimetabolites; Brain; Brain Edema; Myocardium; NAD; NADP; Niacinamide; Nicotinic Acids; P | 1968 |